Completed PHASE4 INTERVENTIONAL 2-arm NCT02570841

Pain Thresholds Under High-dose Topical Capsaicin

Heat-, Cold-, and Mechanical Pain Thresholds Under Exposition of High Dose Topical Capsaicin

Sponsor: Astellas Pharma GmbH

Conditions Pain

Interventions Topical High dose Capsaicin Topical Placebo

Updated 5 times since 2017 Last updated: Oct 5, 2015 Started: Feb 28, 2015 Primary completion: May 31, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain and is currently completed. Astellas Pharma GmbH leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma GmbH
Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria